USD $56.27
BONIVA is a prescription medication that contains the active ingredient Ibandronate. It is primarily used to treat and prevent osteoporosis in postmenopausal women. Osteoporosis is a condition characterized by weakened bones, making them more susceptible to fractures. BONIVA works by inhibiting bone resorption, thereby helping to maintain bone density and reduce the risk of fractures.
IndiaBONIVA (Ibandronate) is a prescription medication used to treat or prevent osteoporosis in postmenopausal women. It belongs to a class of drugs known as bisphosphonates, which help to strengthen bones and reduce the risk of fractures.
The recommended dosage for BONIVA is 3 mg administered as an injection once every three months. It is important to follow your healthcare provider's instructions regarding the dosage and administration of this medication.
Common side effects may include:
Serious side effects are rare but can occur. Contact your healthcare provider immediately if you experience symptoms such as chest pain, difficulty swallowing, or severe bone, joint, or muscle pain.
If you miss a dose of BONIVA, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your normal schedule. Do not double the dose to catch up.
BONIVA is not recommended for use during pregnancy or breastfeeding. Consult your healthcare provider for alternatives if you are pregnant or planning to become pregnant.
Store BONIVA in a cool, dry place away from light. Keep it out of reach of children.
